Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000814133-20-000068
Filing Date
2020-12-03
Accepted
2020-12-03 14:36:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 espr1220.txt SC 13G 2464
  Complete submission text file 0000814133-20-000068.txt   4053
Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS INC (Filed by) CIK: 0000814133 (see all company filings)

EIN.: 870319391 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87536 | Film No.: 201366574
SIC: 2834 Pharmaceutical Preparations